v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Cash flows from operating activities:    
Net loss $ (600,030) $ (345,991)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Common stock issued for service 0 58,000
(Gain) loss on derivative liability 36,779 (13,090)
Loss on debt settlement 1,500 0
Loss on notes 29,630 0
Debt discount 0 9,677
Loan origination fee 10,900 0
Gain on debt extinguishment 0 (773,231)
Change in operating assets and liabilities:    
Increase (decrease) in accounts payable and accrued expenses 123,108 506,860
Increase in payables - related parties 267,484 390,629
Net cash provided by (used in) operating activities (130,629) (167,146)
Cash flows from financing activities    
Proceeds from notes payable- related party 0 6,975
Proceeds from notes payable 163,599 178,000
Repayment on notes payable (34,271) (15,403)
Net cash provided by financing activities 129,328 169,572
Net increase (decrease) in cash (1,301) 2,426
Cash at beginning of period 1,493 171
Cash at end of period 192 2,597
Supplement Disclosures    
Interest Paid 0 0
Income tax Paid 0 0
Noncash financing and investing activities    
Common stock issued for conversion of Series A preferred 0 400,000
Interest accrued on preferred shares 22,068 22,068
Common stock issued for convertible debt 0 65,000
Common stock issued for accrued expenses- related parties 0 704,000
Series B preferred issued notes payable 12,500 0
Series B preferred issued for accrued expense 0 904,409
Series B preferred issued for accrued expense- related parties $ 0 $ 337,992